The Clinical Impact of Camera-Based Positron Emission Tomography Imaging in Patients with Recurrent Colorectal Cancer

Investigative Radiology

Volumn 39, Issue 1, 2004, Pages 8-12

  Miller, Elka ^a   Lerman, Hedva ^a   Gutman, Mordechai ^a   Figer, Arie ^a   Livshitz, Genady ^a   Even Sapir, Einat ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Colorectal cancer; FDG; Gamma camera; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CAMERA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY;

EID: 0346789094     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000091654.32872.57     Document Type: Article

References (18)

1. Ruers TJM, Langenhoff BS, Neeleman N, et al. Value of positron emission tomography with F-18 fluorodeoxyglucose in patients with colorectal liver metastasis: a prospective study. J Clin Oncol. 2002;20:388-395.
2. Flamen BP, Stroobants S, Cutsem EV, et al. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal carcinoma. J Clin Oncol. 1999;17:894-901.
3. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinoma with fluorine-18 fluorodeoxyglucose whole body PET: correlation with histopathologic and CT findings. Radiology. 1998;206:755-760.
4. Lai DT, Fulhman M, Stephen MS, et al. The role of whole-body positron emission tomography with (18F) fluorodeoxyglucose in identifying operable colorectal cancer metastases in the liver. Ann Surg. 1996;131:703-707.
5. Valk PE, Abella-Columna E, Hasemann MK, et al. Whole body PET imaging with F-18 fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg. 1999;134:503-513.
6. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759-770.
7. Delbeke D, Vitola JV, Martin MP, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med. 1997;38:1196-1201.
8. Patton JA, Delbeke D, Sandler MP. Image fusion using an integrated, dual-head coincidence camera with X-ray tube-based attenuation maps. J Nucl Med. 2000;41:1364-1368.
9. Kunze WD, Baehre M, Richter E. PET with a dual-head coincidence camera: spatial resolution, scatter fraction and sensitivity. J Nucl Med. 2000;41:1067-1074.
10. Even-Sapir E, Lerman H, Figer A, et al. The role of fluorine-18-fluorodeoxyglucose (FDG) dual-head gamma camera coincidence imaging in recurrent metastatic colorectal carcinoma. J Nucl. J Nucl Med. 2002;43:603-609.
11. Even-Sapir E, Lerman H, Miller E, et al. The role of fluorine-18-fluorodeoxyglucose (FDG) dual-head gamma camera coincidence imaging in patients with colorectal cancer and unexplained rising levels of carcinoembryonic antigen (CEA). Gastrointest Oncol. 2002;4:133-138.
12. Lonneux M, Reffad AM, Detry R, et al. FDG-PET improves the staging and selection of patients with recurrent colorectal cancer. Eur J Nucl Med. 2002;29:915-921.
13. Steele G, Bleday R, Mayer RJ, et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: gastrointestinal tumor study group protocol 6584. J Clin Oncol. 1991;9:1105-1112.
14. 18F-FDG-PET on managing patients with colorectal cancer: the referring physician's perspective. J Nucl Med. 2001;42:586-590.
15. 18F-FDG-PET in patients with suspect or confirmed recurrence of colorectal cancer: a prospective study. J Nucl Med. 2002;43:492-499.
16. 18F-FDG detection with a dual-head coincidence camera: a review. Eur J Nucl Med. 2001;28:763-778.
17. Shreve PD, Steventon RS, Deters EC, et al. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology. 1998;207:431-437.
18. Boren EL Jr Delbeke D, Patton JA, et al. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch Nal(T1) crystals in patients with suspected body malignancies. Eur J Nucl Med. 1999;26:379-387.